ISSN: 2153-0645
Journal of Pharmacogenomics & Pharmacoproteomics received 613 citations as per Google Scholar report
Commentary
Epigenetic Mechanisms in Health Therapeutic Development and Innovations in Medicine: Phenotypic Diversity Analysis
DOI: 10.35248/2153-0645.24.15.113
Role of COMT, FUT2 and MTHFR Polymorphisms in Personalized Medicine: Implications for Drug Response and Disease Susceptibility
DOI: 10.35248/2153-0645.24.15.114
Genetic Polymorphisms in CYP450 Enzymes: Implications for Drug Interaction Risk and Therapeutic Outcomes
DOI: 10.35248/2153-0645.24.15.115
Short Communication
Chemotherapeutic Drugs and DNA Damage Degradation in the Context of Antiretroviral Drug Resistance
DOI: 10.35248/2153-0645.24.15.116
Perspective
Human Cancer Stem Cells in Predicting Efficacy and Toxicity of Chemotherapeutic Drugs for Cancer-Specific DNA Damage
DOI: 10.35248/2153-0645.24.15.117
Toxicogenomics and the Development of Biomarkers for Predicting Toxicity in Drug Discovery
DOI: 10.35248/2153-0645.24.15.118
Advancing Platelet Proteomics and Lipidomics: Clinical Insights into Thrombotic and Inflammatory Disorders
DOI: 10.35248/2153-0645.24.15.119
Opinion Article
Analyzing the Genome and Understanding the Role of DNA, Chromosomes and Genetic Variation in Personalized Medicine
DOI: 10.35248/2153-0645.24.15.120
Advancing Drug Development with Epigenomics and Pharmacodynamics: Implications for Clinical Practice
DOI: 10.35248/2153-0645.24.15.121
Pharmacogenomic and Immune Implications of Small Nucleolar RNAs in Cancer: From Mechanisms to Therapeutic Strategies
DOI: 10.35248/2153-0645.24.15.122